Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ
Condition: Major Depressive DisorderIntervention: Sponsor: PfizerNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2015 Category: Research Source Type: clinical trials
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
Condition: Major Depressive DisorderInterventions: Drug: Desvenlafaxine; Drug: PlaceboSponsors: University of Calgary; University of AlbertaRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2014 Category: Research Source Type: clinical trials
Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
Condition: DepressionInterventions: Drug: Duloxetine; Drug: Venlafaxine; Drug: Desvenlafaxine; Drug: Citalopram; Drug: Escitalopram; Drug: Fluoxetine; Drug: Fluvoxamine; Drug: Paroxetine; Drug: SertralineSponsors: Canadian Network for Observational Drug Effect Studies; Drug Safety and Effectiveness Network (DSEN); Canadian Institutes of Health Research (CIHR)Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2014 Category: Research Source Type: clinical trials
